Welcome toSecond Life, a podcast spotlighting successful women who've made major career changes—and fearlessly mastered the pivot. Hosted by Hillary Kerr, co-founder and chief content officer at Who What Wear, each episode gives you a direct line to women who are game changers in their fields. Subscribe to Second Life on Apple Podcasts, Spotify, or anywhere you get your podcasts to stay tuned.
There is a common wellness declaration that your overall health begins in your gut — and it’s true. Ara Katz, the co-founder and co-CEO of microbiome science company Seed Health, is one of the biggest gut health advocates proving the science behind the importance of gut health through pioneering innovations in probiotics and living medicines. Katz launched Seed Health in 2015 with the mission to set a new standard for gut health by defining the direct correlation between what goes on in your gut and how it affects the body’s overall health, including your skin, heart, digestion, and more.
Seed Health’s hero product, the Daily Synbiotic, is a two-in-one daily capsule containing both a probiotic and prebiotic to support gut health that has completely revolutionized the daily prebiotic supplement. And last year, Katz impressively raised 40 million dollars in seed funding, which she’s using to expand clinical research and global distribution. But, as Katz continues to be at the helm of a company that stands at the intersection of health, consumer tech, media, and design, it may come as a surprise that her first career life was in a completely different industry. Prior to starting her own science company, Katz co-founded the mobile-commerce startup Spring, which was backed by LVMH, where she helped launch ApplePay on the iPhone.
Listen to the latest episode of Second Life to hear how Katz found the path — through both her personal and professional life — to create a product that is genuinely making a positive impact on our health.
Next: Meet Lisa Bühler, The Creator Behind Lisa Says Gah.
from Who What Wear https://ift.tt/Ka5j0hw
No comments:
Post a Comment